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Fig. 1 Chemical structures of pisiferic acid (A) and carnosic acid (B).
Fig. 2 Inhibitory effect of PA in the ex vivo angiogenesis model. A Repre-
sentative result of PA (100 µM). B Microvessel length was measured on day
7. Values are the means ± SEM (n = 3). Significant difference from the con-
trol: **p < 0.01. CA (50 µM) was used as a positive control.
e31Letter
THIEMEInhibitory Effects of Pisiferic Acid on
Angiogenesis and Lymphangiogenesis
Sachi Shibata1, Mitsuyoshi Yatagai2, Yoshiko Tateishi3,
Kiminori Matsubara1
1 Department of Human Life Science Education, Graduate School of
Education, Hiroshima University, Hiroshima, Japan
2 Supporting Organization for Research of Agricultural and Life
Sciences, Tokyo, Japan
3 Department of Environmental Dynamics and Management,




Pisiferic acid, a diterpene isolated from Chamaecyparis pisifera,
has a chemical structure similar to carnosic acid, which has anti-
oxidant activity and exerts various biological effects such as anti-
biotic and antiangiogenic activity. However, the effect of pisiferic
acid on angiogenesis, which is involved in various diseases in-
cluding cancer and diabetic retinopathy, has not been elucidated.
We found that pisiferic acid inhibited angiogenesis and sup-
pressed human umbilical vein endothelial cell tube formation
and proliferation but had no effect on human umbilical vein en-
dothelial cell chemotaxis. Furthermore, in lymphangiogenesis as-
says, pisiferic acid inhibited lymphangiogenesis and lymphatic
endothelial cell tube formation and proliferation. Together, these
results suggest pisiferic acid to be a useful natural compound,
such as carnosic acid, with beneficial effects on angiogenesis-
and lymphangiogenesis-related diseases.
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PA is an abundant natural product found in the leaves of the
Japanese tree Sawara [Chamaecyparis pisifera (Siebold & Zucc.)
Endl.; Cupressaceae] (l" Fig. 1A) [1], and has been reported to
have various biological activities including DNA polymerase inhi-
bition [2], chitin synthase inhibition [3], and antibiotic activity
[4]. It also affects cell signaling pathways in HL60 cells and yeast
[5,6]. PA has been used for the synthesis of its derivative CA
(l" Fig. 1B) [7]. CA has been extensively studied and reported to
have various biological activities such as antioxidant activity,
promotion of neurite outgrowth, and a protective effect on the
nerve system [8–10]. Recently, we have reported that CA is an in-hibitor of angiogenesis [11]. Angiogenesis refers to the formation
of new blood vessels and is involved in various diseases such as
cancer, diabetic retinopathy, and rheumatoid arthritis [12]. Thus,
natural products that inhibit angiogenesis have drawn attention
for the development of angiogenesis inhibitors. While CA has
been known to inhibit angiogenesis, the effect of PA on angiogen-
esis has not been reported thus far. In this study, we examined
the effect of PA on angiogenesis, and, furthermore, on lymphan-
giogenesis, which is also involved in inflammation and various
diseases [13].
In an ex vivo angiogenesis assay using the rat aortic ring, PA sup-
pressed the outgrowth of microvessels that grew in a week, as
shown in l" Fig. 2. At 50 µM, PA completely inhibited angiogene-
sis, whereas CA suppressed angiogenesis by about 40% at the
same concentration. However, PA did not show a suppressive ef-
fect at 25 µM, but CA significantly suppressed angiogenesis at this
concentration [11].Shibata S et al. Inhibitory Effects of… Planta Med Int Open 2016; 3: e31–e34
Fig. 3 Effect of PA on HUVEC tube formation on a reconstituted basement
membrane. (A) HUVEC tube formation on reconstituted gel was observed
at 12 h, and the capillary length (B) was measured. Values are the means ±
SD (n = 7–12). Significant difference from the control: **p < 0.01. CA
(50 µM) was used as a positive control.
Fig. 4 Effect of PA on HUVEC proliferation. Values are the means ± SD
(n = 10). Significant difference from the control: *p < 0.05 and **p < 0.01.
CA (50 µM) was used as a positive control.
Fig. 5 Effect of PA on HUVEC chemotaxis. Migrated cells after 6 h incuba-
tion were counted. Values are the means ± SEM (n = 3). Significant differ-
ence from the control: **p < 0.01. CA (50 µM)was used as a positive control.
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fect in some models using HUVECs. PA significantly suppressed
HUVEC tube formation and proliferation at 50 µM and 25 µM, re-
spectively (l" Figs. 3 and 4), but had no effect on HUVEC migra-
tion induced by VEGF (l" Fig. 5). Thus, PA exerts antiangiogenic
activity by suppressing endothelial cell capillary formation and
proliferation. CA exerted suppressive effects in all three HUVEC
assays as previously reported [11]. These results suggest that the
inhibitory mechanisms by which both compounds exert anti-
angiogenic activity are different, and that the difference could
be attributed to their structural difference. In the HUVEC migra-
tion assay, VEGF was used to induce HUVEC migration, but in
HUVEC tube formation and proliferation assays, the used me-
dium contained bFGF, and not VEGF, suggesting that PA may not
affect the VEGF receptor-mediated cell signaling pathway. Re-
cently, the antiangiogenic activity of fucoxanthin and siphon-
axanthin, both natural compounds, has been reported [14,15].
Both carotenoids did not affect VEGF-induced HUVEC migration,
and we demonstrated that both carotenoids downregulated the
FGF-2 (bFGF) signaling pathway [16]. Thus, PA might exert its in-
hibitory effect on angiogenesis in a similar manner. Other deriva-
tives of PA might have unique effects on endothelial cells and
angiogenesis.
Lymphangiogenesis is also an important target for preventing
various diseases such as cancer and inflammatory conditions. To
clarify whether PA affects lymphangiogenesis, we examined its
effect in an ex vivo lymphangiogenesis model [17]. Since the
method was slightly modified, immunohistochemical analysis
was performed to confirm the induction of lymphangiogenesis
in the model. The morphology of capillaries was the same as that
reported previously (l" Fig. 6), and the anti-LYVE‑1 antibody re-
acted with the capillaries (data not shown), confirming the oc-Shibata S et al. Inhibitory Effects of… Planta Med Int Open 2016; 3: e31–e34currence of lymphangiogenesis. PA completely inhibited lym-
phangiogenesis at 100 µM and strongly inhibited it at 50 µM in
the model (l" Fig. 6). Since PA suppressed HUVEC tube formation
and proliferation, we examined its effect on LEC tube formation
and proliferation. PA exerted inhibitory effects in both assays
(l" Figs. 7 and 8), suggesting that PA exerts inhibitory effects tar-
geting the samemolecules on both endothelial cells for angiogen-
esis and lymphangiogenesis. Recently, it has been demonstrated
that FGF-2 (bFGF) and VEGF‑C, an angiogenesis and lymphangio-
genesis enhancing growth factor, respectively, collaboratively
stimulate tumor growth, angiogenesis, lymphangiogenesis, and
metastasis [18]. Thus, natural products suppressing both angio-
genesis and lymphangiogenesis or the bFGF pathway would be
useful as anticancer agents. Although elucidation of the mecha-
nism by which PA exerts antilymphangiogenic activity is neces-
sary, this study suggests that PA might be beneficial in suppress-
ing both angiogenesis- and lymphangiogenesis-related diseases.
In this study, we found that PA suppresses both angiogenesis and
lymphangiogenesis. We previously reported the antiangiogenic
Fig. 6 Inhibitory effect of PA in the ex vivo lymphangiogenesis model.
A Representative result of PA (100 µM). B Microvessel length was mea-
sured on day 7. Values are themeans ± SEM (n = 3–4). Significant difference
from the control: **p < 0.01. EGCG (50 µM) was used as a positive control.
Fig. 7 Effect of PA on LEC tube formation on a reconstituted basement
membrane. (A) LEC tube formation on reconstituted gel was observed at
12 h, and the capillary length (B) was measured. Values are the means ± SD
(n = 3). Significant difference from the control: **p < 0.01. EGCG (50 µM)
was used as a positive control.
Fig. 8 Effect of PA on LEC proliferation. Values are the means ± SD (n = 5).
Significant difference from the control: *p < 0.05. EGCG (50 µM) was used
as a positive control.
e33Letter
THIEMEeffect of CA, whose chemical structure is very similar to PA. The
inhibitory effects of PA on angiogenesis are similar to that of CA,
but its effect on HUVECs is different. CA suppresses HUVEC tube
formation, proliferation, and migration, whereas PA has no effect
on HUVEC migration. This difference in biological activity could
be attributed to the difference in their targets on endothelial
cells. To reveal the difference, our study focused on their effects
on cell signaling pathways. CA is a unique compound because it
has various biological effects, especially in the neural system.
PA is used for the synthesis of CA [7]. If PA exerts similar effects
as CA in the neural system, PA may be used instead of CA. Thus,
research is underway, and we have found that PA affects neural
cell function similar to CA, but the mechanisms seem to be differ-
ent (unpublished data). The difference would be related to their




PA (purity > 99%), isolated as previously described [1], was dis-
solved in DMSO to 20mM as a stock solution, and kept at − 25°C
until use. As positive control inhibitors, CA (purity > 91%) from
Sigma-Aldrich and (−)-epigallocatechin gallate (EGCG; purity
> 99%) from Nacalai Tesque were used for angiogenesis [11] and
lymphangiogenesis [19], respectively. The purity of all com-
pounds was determined by HPLC. All animal experiments were
approved by the animal experiment committee of Hiroshima
University Animal Research Committee; the approval numbers
were C11-1 (2011/04/12) and C13–2 (2013/04/11). The ex vivo
angiogenesis assay was performed according to a previously re-
ported method [20,21]. The ex vivo lymphangiogenesis assay
was performed according to a previously described method, withsome modifications [17]. Rat thoracic ducts were excised from
the rats and cut into approximately 1mmsections under a stereo-
microscope. The lymphatic duct rings were embedded in type I
collagen gel in a 6-well culture plate as described in the ex vivo
angiogenesis assay (Supporting Information). After 30min to
form a gel at 37°C in a CO2 incubator, 2mL of RPMI 1640 medium
(Gibco) containing 10% FBS (Lonza), 100 U/mL penicillin, and
100 µg/mL streptomycin (Gibco) were added to the wells. PA or
EGCG solution or DMSO was added, and the plates were incu-
bated for 7 days at 37°C in a CO2 incubator. The images of theShibata S et al. Inhibitory Effects of… Planta Med Int Open 2016; 3: e31–e34
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THIEMElymphatic rings were taken with a digital camera (OLYMPUS
DSE330-A system), and the length of the capillaries was mea-
sured using Adobe Photoshop software.
Supporting information
A detailed description of the ex vivo angiogenesis assay and in vi-
tro assays using HUVEC and LEC and statistical analysis are avail-
able as Supporting Information.
Acknowledgements
!
This work was supported in part by grants from JSPS KAKENHI,
grant numbers 22580130 and 26450159 (K.M.).
Conflict of Interest
!
The authors declare no conflict of interest.
References
1 Yatagai M, ShiratoT, Hayashi Y, Fukuhara N, Takahashi T. Pisiferic acid, a
new phenolic diterpene carboxylic acid from Chamaecyparis pisifera S.
et Z. J Jpn Wood Res Soc 1978; 24: 267–269
2 Kobayashi K, Kuroda K, Shinomiya T, Nishino C, Ohya J, Sato S. Effect of
pisiferic acid and its derivatives on cytotoxicity macromolecular syn-
thesis and DNA polymerase alpha of HeLa cells. Int J Biochem 1989;
21: 463–468
3 Kang TH, Hwang EI, Yun BS, Shin CS, Kim SU. Chitin synthase 2 inhib-
itory activity of O-methyl pisiferic acid and 8, 20-dihydroxy-9(11),
13-abietadien-12-one, isolated from Chamaecyparis pisifera. Biol
Pharm Bull 2008; 31: 755–759
4 Xiao D, Kuroyanagi M, Itani T, Matsuura H, Udayama M, Murakami M,
Umehara K, Kawahara N. Studies on constituents from Chamaecyparis
pisifera and antibacterial activity of diterpenes. Chem Pharm Bull (To-
kyo) 2001; 49: 1479–1481
5 Aburai N, Yoshida M, Ohnishi M, Kimura K. Pisiferdiol and pisiferic acid
isolated from Chamaecyparis pisifera activate protein phosphatase 2C
in vitro and induce caspase-3/7-dependent apoptosis via dephosphor-
ylation of Bad in HL60 cells. Phytomedicine 2010; 17: 782–788
6 Aburai N, Yoshida J, Kobayashi M, Mizunuma M, Ohnishi M, Kimura K.
Pisiferdiol restores the growth of a mutant yeast suffering from
hyper-activated Ca2+-signaling through calcineurin inhibition. FEMS
Yeast Res 2013; 13: 16–22
7 Tada M, Ohkanda T, Kurabe J. Syntheses of carnosic acid and carnosol,
anti-oxidants in Rosemary, from pisiferic acid, the major constituent of
Sawara. Chem Pharm Bull (Tokyo) 2010; 58: 27–29
8 Aruoma OI, Halliwell B, Aeschbach R, Loligers J. Antioxidant and pro-
oxidant properties of active rosemary constituents: carnosol and car-
nosic acid. Xenobiotica 1992; 22: 257–268
9 Kosaka K, Mimura J, Itoh K, Satoh T, Shimojo Y, Kitajima C, Maruyama A,
Yamamoto M, Shirasawa T. Role of Nrf2 and p62/ZIP in the neurite out-
growth by carnosic acid in PC12 h cells. J Biochem 2010; 147: 73–81
10 Satoh T, Rezaie T, Seki M, Sunico CR, Tabuchi T, Kitagawa T, Yanagitai M,
Senzaki M, Kosegawa C, Taira H, McKercher SR, Hoffman JK, Roth GP, Lip-
ton SA. Dual neuroprotective pathways of a pro-electrophilic com-
pound via HSF‑1-activated heat-shock proteins and Nrf2-activatedShibata S et al. Inhibitory Effects of… Planta Med Int Open 2016; 3: e31–e34phase 2 antioxidant response enzymes. J Neurochem 2011; 119: 569–
578
11 Kayashima T, Matsubara K. Antiangiogenic effect of carnosic acid and
carnosol, neuroprotective compounds in rosemary leaves. Biosci Bio-
technol Biochem 2012; 76: 115–119
12 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other dis-
ease. Nat Med 1995; 1: 27–31
13 Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development
and human disease. Nature 2005; 438: 946–953
14 Sugawara T, Matsubara K, Akagi R, Mori M, Hirata T. Antiangiogenic
activity of brown algae fucoxanthin and its deacetylated product,
fucoxanthinol. J Agric Food Chem 2006; 54: 9805–9810
15 Ganesan P, Matsubara K, Ohkubo T, Tanaka Y, Noda K, Sugawara T,
Hirata T. Anti-angiogenic effect of siphonaxanthin from green alga,
Codium fragile. Phytomedicine 2010; 17: 1140–1144
16 Ganesan P, Matsubara K, Sugawara T, Hirata T.Marine algal carotenoids
inhibit angiogenesis by down-regulating FGF‑2-mediated intracellular
signals in vascular endothelial cells. Mol Cell Biochem 2013; 380: 1–9
17 Bruyere F, Melen-Lamalle L, Blacher S, Roland G, Thiry M, Moons L,
Frankenne F, Carmeliet P, Alitalo K, Libert C, Sleeman JP, Foidart JM, Noel
A. Modeling lymphangiogenesis in a three-dimensional culture sys-
tem. Nat Methods 2008; 5: 431–437
18 Cao R, Ji H, Feng N, Zhang Y, Yang X, Andersson P, Sun Y, Tritsaris K, Han-
sen AJ, Dissing S, Cao Y. Collaborative interplay between FGF‑2 and
VEGF‑C promotes lymphangiogenesis and metastasis. Proc Natl Acad
Sci U S A 2012; 109: 15894–15899
19 Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE. Epigallocate-
chin-3-gallate inhibits stem-like inflammatory breast cancer cells.
PLoS One 2013; 8: e73464
20 Mori M, Sadahira Y, Kawasaki S, Hayashi T, Notohara K, Awai M. Capil-
lary growth from reversed rat aortic segments cultured in collagen gel.
Acta Pathol Jpn 1988; 38: 1503–1512
21 Matsubara K, Mori M, Matsuura Y, Kato N. Pyridoxal 5′-phosphate and
pyridoxal inhibit angiogenesis in serum-free rat aortic ring assay. Int
J Mol Med 2001; 8: 505–508
received August 24, 2015
revised November 17, 2015
accepted April 10, 2016
Bibliography
DOI http://dx.doi.org/10.1055/s-0042-107801
Planta Med Int Open 2016; 3: e31–e34
© Georg Thieme Verlag KG Stuttgart · New York ·
ISSN 2509‑6656
Correspondence
Associate Prof. Dr. Kiminori Matsubara
Department of Human Life Sciences Education
Graduate School of Education
Hiroshima University
1-1-1 Kagamiyama
Higashi-Hiroshima 739-8524
Japan
Phone: + 81824246854
Fax: + 81824227133
kmatsuba@hiroshima-u.ac.jpLicense terms
